Balyasny Asset Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-117,487
Closed -$6.2M 2013
2024
Q3
$6.2M Sell
117,487
-483,880
-80% -$25.5M 0.01% 805
2024
Q2
$32.6M Sell
601,367
-73,695
-11% -$3.99M 0.06% 335
2024
Q1
$47.3M Buy
675,062
+261,925
+63% +$18.4M 0.08% 243
2023
Q4
$34.5M Sell
413,137
-765,741
-65% -$63.9M 0.06% 288
2023
Q3
$34.7M Buy
1,178,878
+107,346
+10% +$3.16M 0.07% 302
2023
Q2
$35M Buy
1,071,532
+119,528
+13% +$3.9M 0.08% 296
2023
Q1
$33.5M Buy
952,004
+70,596
+8% +$2.48M 0.08% 275
2022
Q4
$40.4M Buy
881,408
+598,160
+211% +$27.4M 0.11% 183
2022
Q3
$13.7M Buy
283,248
+94,609
+50% +$4.58M 0.04% 450
2022
Q2
$7.41M Buy
+188,639
New +$7.41M 0.02% 629
2022
Q1
Sell
-9,911
Closed -$452K 2185
2021
Q4
$452K Sell
9,911
-27,004
-73% -$1.23M ﹤0.01% 1417
2021
Q3
$1.32M Buy
+36,915
New +$1.32M 0.01% 1052
2020
Q4
Sell
-125,298
Closed -$2.71M 1217
2020
Q3
$2.71M Buy
+125,298
New +$2.71M 0.02% 599
2018
Q1
Sell
-19,877
Closed -$162K 1786
2017
Q4
$162K Sell
19,877
-822,118
-98% -$6.7M ﹤0.01% 1689
2017
Q3
$12.2M Buy
841,995
+210,195
+33% +$3.05M 0.05% 377
2017
Q2
$7.65M Buy
631,800
+124,300
+24% +$1.5M 0.03% 521
2017
Q1
$6.52M Buy
507,500
+181,925
+56% +$2.34M 0.03% 541
2016
Q4
$3.96M Buy
+325,575
New +$3.96M 0.02% 595
2016
Q2
Sell
-176,559
Closed -$1.25M 1026
2016
Q1
$1.25M Sell
176,559
-55,871
-24% -$394K 0.01% 555
2015
Q4
$2.43M Buy
+232,430
New +$2.43M 0.02% 526